The market was valued at USD 90,400 million in 2025 and is anticipated to reach USD 146,500 million by 2035, expanding at a compound annual growth rate (CAGR) of 4.8% over the forecast period.

Country-wise Outlook

Competitive Outlook

In 2020, the in vitro-diagnostics market is expected to be dominated by consumable products with a share of 70 percent. The statistic shows the estimated distribution of the global in-vitro diagnostics market in 2020 and a forecast for 2030, by type of product.

The in Vitro Diagnostics Market Report is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, and More), Product (Instruments, Reagents and More), Usability (Disposable IVD Devices, Reusable Equipment), Application (Infectious Diseases, Oncology, Cardiology, and More), End User (Stand-Alone Laboratories, and More), Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

In 2029, the global in vitro diagnostics market is forecast to have revenue of over ***** billion U.S. dollars. Between 2020 and 2021, the IVD market size increased significantly, going from around ** billion U.S. dollars to just under 100 billion U.S. dollars. Market leaders and regional distribution Swiss-based pharmaceutical company Roche has maintained its position as the global leader in the IVD market, with projected revenues exceeding ** billion U.S. dollars by 2024. Other major players include Abbott Laboratories and Danaher from the United States. In Europe, Germany dominates the IVD market with a ** percent share, more than double that of France, the next largest market at **** percent. Market composition The IVD market comprises various product categories, including reagents, instruments, and software services. Consumable products accounted for the largest share of the IVD market globally, representing around ** percent of the total market.

This statistic describes the top 10 medical technology companies for in vitro diagnostics in 2017 and 2024, based on market share. In 2017, Sysmex accounted for 4.4 percent of the global market for in vitro diagnostics. By 2024, this share is expected to increase slightly to 4.5 percent. In vitro diagnostics allows for medical professionals to detect diseases, conditions, and infections. These tests can be conducted within a laboratory and sometimes at within a patient's home.

In vitro diagnostics market size is expected to grow from USD 108 billion in 2024 to USD 113 billion in 2025 and USD 190 billion by 2035, at a CAGR of 5.3%

The global in vitro diagnostics market size reached USD 116.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 181.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.0% during 2025-2033. The rising prevalence of infectious diseases globally, the continuous technological advancements, the shifting consumer preferences towards personalized medicine, and the increasing geriatric population are among the primary factors driving the in vitro diagnostics market growth.

IMARC Group provides an analysis of the key trends in each segment of the global in vitro diagnostics market report, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on test type, product, usability, application, and end user.

Stay Updated on IVD(In-Vitro Diagnostics) Market - Analysis and Forecast 2017-2023 from BIS Research Focuses on Region, key player, Total revenue, challenges, and growth opportunities.

As per Cognitive Market Research's latest published report, the Global In Vitro Diagnostics market size will be $87,826.93 Million by 2028.In Vitro Diagnostics Industry's Compound Annual Growth Rate will be 4.48% from 2023 to 2030.

North America In Vitro Diagnostics market size will be USD 30,196.36 Million by 2028.

What is Driving In Vitro Diagnostics Industry Growth?

Rise in the geriatric population

The rise in the adoption of advanced healthcare systems, new diagnostic techniques and adoption of medicines, have led to a significant decline in mortality rates, thereby accelerating the life expectancy.

Moreover, the early detection of the diseases and adoption of advanced diagnostic tools, including the over-the-counter diagnostic products, including glucose monitoring kits, are present in the market. These products are adopted by the elderly to reduce hospital visits.

Moreover, the development in the health care system, and early detection of diseases, and advanced treatment options, are some of the factors, which have extended the life expectancy, thereby leading to the rise in the geriatric population.

According to the World Health Organization (WHO), by 2050, the world’s population aged 60 years and above is expected to reach around 2 billion, that has increased from 900 million in 2015.

Additionally, according to the data published by UN, the global population aged 60 years or over numbered 962 million in 2017, has witnessed a significant rise, as large as in 1980 when there were 382 million geriatric people across the world.

The rise in the life expectancy is associated with the presence of several diseases, including the rise in the cardiovascular disease, diabetes, chronic low back pain is some of the factors, which have an inversely proportional rise in the demand for the invitro diagnostics.

Additionally, the immune system is affected owing to the rise in the age, which increases susceptibility to acquiring various diseases. Therefore, a significantly geriatric population needs access to advanced healthcare systems, especially for chronic diseases.

Therefore, the growth in the geriatric population is expected to increase the prevalence of various diseases across the globe. Thus, it is considered as one of the significant factors driving the growth of the invitro diagnostics market.

Restraints for In Vitro Diagnostics Market

High cost of devices and unfavorable reimbursement scenario’s.(Access Detailed Analysis in the Full Report Version)

Opportunities for In Vitro Diagnostics Market

Increasing R&D investments.(Access Detailed Analysis in the Full Report Version)

Introduction of In Vitro Diagnostics

A range of tools is used by health care practitioners to diagnose illnesses and guide treatment decisions. In-vitro diagnostics (IVDs), which are clinical tests that examine samples obtained from the human body, are among the most popular and commonly utilized.

In-vitro diagnostics are tests performed on samples obtained from the human body, such as blood or tissue. It can identify illnesses and other disorders, as well as monitor a person's general health to assist in the cure, treatment, or prevention of diseases.

IVDs are used to analyze human samples like blood and saliva, either by measuring the concentration of specific substances, or analytes (like sodium and cholesterol) or by detecting the presence or absence of a specific marker or set of markers, like a genetic mutation or an immune response to infection.

Precision medicine also employs in vitro diagnostics to identify patients who are likely to benefit from certain treatments or therapies. These in vitro diagnostics can involve next-generation sequencing tests, which analyze a person's DNA for genetic changes.

In-vitro diagnostics can be performed in laboratories, hospitals, or even at home. IVD tests are often conducted in a stand-alone laboratory, a hospital-based laboratory, or a point-of-care (POC) center, and typically comprise polymerase chain reaction (PCR), microarray methods, sequencing technologies, and mass spectrometry.

The tests themselves can be carried out on a wide range of tools, from simple portable devices to complicated laboratory equipment. It also made use of reagents that enable doctors to accurately diagnose patients and work to deliver suitable therapies.

Several...

In Vitro Diagnostics Market Outlook

The global In Vitro Diagnostics (IVD) market size was valued at approximately $82 billion in 2023 and is projected to reach around $110 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.2%. The market's growth is primarily driven by the rising prevalence of chronic diseases, increasing geriatric population, and advancements in diagnostic technologies.

The rising prevalence of chronic and infectious diseases globally is one of the key growth factors for the IVD market. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require frequent diagnostic testing, which drives the demand for IVD products. Additionally, the recent COVID-19 pandemic underscored the importance of diagnostics in managing public health, further boosting the market. The increasing incidence of infectious diseases, including emerging and re-emerging infections, has also led to higher demand for rapid and accurate diagnostic tests.

Another significant growth factor is the growing geriatric population worldwide, which is more susceptible to various diseases. As the global population ages, the demand for diagnostic tests that can identify and manage age-related diseases is expected to rise. This demographic shift, coupled with an increase in healthcare expenditure, particularly in developed economies, supports the expansion of the IVD market. The elderly population often requires more frequent diagnostic testing, contributing to the market's sustained growth over the forecast period.

Technological advancements in the field of diagnostics have also played a crucial role in driving the market. Innovations such as next-generation sequencing, digital pathology, and AI-powered diagnostic tools have significantly enhanced the accuracy and efficiency of diagnostic tests. The integration of these advanced technologies in IVD products has led to improved disease detection and patient outcomes. Additionally, the development of point-of-care (POC) diagnostics has made it possible to conduct tests outside traditional laboratory settings, further boosting market growth.

In Vitro Diagnostics Devices have become a cornerstone in the healthcare industry, providing essential tools for disease detection and management. These devices encompass a wide range of equipment used to perform tests on samples such as blood, urine, and tissue. The evolution of these devices has been marked by significant technological advancements, enabling more precise and rapid diagnostics. As healthcare systems worldwide strive for efficiency and accuracy, the demand for state-of-the-art In Vitro Diagnostics Devices continues to rise. These devices not only improve patient outcomes by facilitating early detection but also support healthcare providers in making informed treatment decisions. The integration of digital technologies and automation in these devices further enhances their capabilities, making them indispensable in modern medical practice.

Regionally, North America holds the largest share of the IVD market, driven by high healthcare expenditure, well-established healthcare infrastructure, and the presence of major market players. Europe follows closely due to similar factors. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period, supported by increasing healthcare investments, rising awareness about early disease diagnosis, and a growing patient population. The region's large population base and improving healthcare infrastructure present significant opportunities for market expansion.

Product Type Analysis

The IVD market by product type is segmented into instruments, reagents, software, and services. Instruments constitute a significant segment due to their essential role in conducting diagnostic tests. These include analyzers, automation systems, and point-of-care devices, which are critical for various diagnostic applications. The continuous advancements in instrumentation technology, such as the development of high-throughput systems and integrated platforms, are driving the growth of this segment. Moreover, the increasing adoption of automation in laboratories to enhance efficiency and reduce turnaround times is further propelling the demand for diagnostic instruments.

Reagents are another crucial segment within the IVD market, encompassing a wide range of chemical, biological, and immunological substances used in

In-vitro Diagnostics Market Outlook

According to our latest research, the global in-vitro diagnostics (IVD) market size reached USD 102.6 billion in 2024. The market is currently experiencing robust expansion, supported by a CAGR of 5.4% during the forecast period. By 2033, the in-vitro diagnostics market is projected to attain a value of USD 163.4 billion. This growth is primarily driven by the increasing prevalence of chronic and infectious diseases worldwide, ongoing technological advancements in diagnostic tools, and the rising emphasis on early disease detection and personalized medicine.

One of the most significant growth drivers for the in-vitro diagnostics market is the rising global burden of chronic and infectious diseases. The increasing incidence of conditions such as diabetes, cancer, cardiovascular diseases, and infectious diseases like tuberculosis and HIV has heightened the demand for early and accurate diagnostic solutions. Early diagnosis is crucial for effective disease management, leading to improved patient outcomes and reduced healthcare costs. Additionally, the emergence of new infectious threats and pandemics, as witnessed during the COVID-19 crisis, has further underscored the vital role of IVD in rapid screening and disease surveillance, prompting both public and private sectors to invest heavily in diagnostic infrastructure and innovation.

Technological advancements are another key factor propelling the growth of the in-vitro diagnostics market. The integration of cutting-edge technologies such as next-generation sequencing, digital PCR, microfluidics, and artificial intelligence has revolutionized the field of diagnostics. These innovations have enabled higher sensitivity, specificity, and automation in testing, thereby enhancing laboratory efficiency and accuracy. Moreover, the increasing adoption of point-of-care testing (POCT) devices and home-based diagnostic solutions is making healthcare more accessible and patient-centric. The development of multiplex assays and companion diagnostics is also supporting the trend towards personalized medicine, allowing for tailored treatment regimens based on individual patient profiles.

Another important growth factor is the supportive regulatory landscape and increasing healthcare expenditure globally. Governments and regulatory bodies are streamlining approval processes for novel diagnostic products, ensuring faster access to advanced testing solutions. Furthermore, rising investments by public and private entities in healthcare infrastructure, particularly in emerging economies, are expanding the reach of IVD technologies. Initiatives aimed at strengthening laboratory networks, improving disease surveillance, and enhancing quality assurance are fostering market growth. The growing awareness among patients and healthcare professionals about the benefits of early detection and preventive care is also contributing to the increased adoption of IVD products.

From a regional perspective, North America continues to dominate the in-vitro diagnostics market, accounting for the largest share in 2024, followed by Europe and Asia Pacific. The region’s leadership is attributed to the presence of advanced healthcare systems, high adoption rates of innovative diagnostic technologies, and significant investments in research and development. However, Asia Pacific is expected to exhibit the fastest growth rate during the forecast period, driven by rising healthcare awareness, expanding patient population, and increasing government initiatives to improve diagnostic infrastructure. Latin America and the Middle East & Africa are also witnessing steady growth, supported by improving healthcare access and rising investments in laboratory services.

Product Type Analysis

The in-vitro diagnostics market by product type is segmented into Instruments, Reagents & Kits, and Software & Services. Among these, reagents & kits represent the largest revenue contributor in 2024, owing to their recurring usage in a wide range of diagnostic tests across var

The Global In Vitro Diagnostics (IVD) market is valued at USD 115.6 bn based on a comprehensive historical analysis. This growth is driven by advancements in diagnostic technologies, the rising prevalence of chronic diseases, and the increasing adoption of point-of-care (POC) testing.

The global in vitro diagnostics market was valued at USD 81.78 Billion in 2024, driven by the increasing demand for advanced diagnostic facilities across the globe. The market is anticipated to grow at a CAGR of 6.20% during the forecast period of 2025-2034 to achieve a value of USD 149.24 Billion by 2034.

In Vitro Diagnostics Ivd Market is estimated to be valued at USD 126.73 Bn in 2025 and is expected to expand at CAGR of 6.5% reachingUSD 197.06 Bn by 2032

Snapshot img

In-Vitro Diagnostics (IVD) Market Size 2025-2029

The in-vitro diagnostics market size is valued to increase USD 28.8 billion, at a CAGR of 4.6% from 2024 to 2029. Increasing geriatric population, chronic and infectious diseases will drive the in-vitro diagnostics (ivd) market.

Major Market Trends & Insights

North America dominated the market and accounted for a 44% growth during the forecast period.
By Product Type - Reagents and kits segment was valued at USD 70.30 billion in 2023
By Technology - Immunoassay segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 41.35 billion
Market Future Opportunities: USD 28.80 billion
CAGR : 4.6%
North America: Largest market in 2023

Market Summary

The market represents a significant and continually evolving sector within the healthcare industry. This market encompasses a range of diagnostic tests conducted outside the body, utilizing various core technologies such as immunoassays, molecular diagnostics, and clinical chemistry. The applications of IVDs span from infectious disease testing to genetic screening and drug monitoring. The global adoption of advanced treatment solutions and the increasing geriatric population are major drivers propelling the growth of this market. 
Stringent regulatory bodies, such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), guide in-vitro diagnostics manufacturers, ensuring the highest standards for accuracy and safety. However, challenges persist, including the high cost of IVDs and the need for continuous innovation to address emerging diseases and diagnostic demands. Despite these hurdles, opportunities abound, particularly in emerging markets and in the development of point-of-care (POC) diagnostics, which offer increased accessibility and convenience. In summary, the In-Vitro Diagnostics Market is a dynamic and essential component of the healthcare industry, driven by technological advancements, demographic shifts, and regulatory requirements.
With a projected growth rate of approximately 5% per year, this market is poised for continued expansion and innovation.

What will be the Size of the In-Vitro Diagnostics (IVD) Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the In-Vitro Diagnostics (IVD) Market Segmented and what are the key trends of market segmentation?

The in-vitro diagnostics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product Type

  Reagents and kits
  Instruments
  Others


Technology

  Immunoassay
  Molecular diagnostics
  Clinical chemistry
  Hematology
  Others


Application

  Oncology
  Cardiology
  Autoimmune diseases
  Neurology
  Others


End-user

  Hospitals and clinics
  Research institutes
  Diagnostics laboratories
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Middle East and Africa

    Egypt
    KSA
    Oman
    UAE


  APAC

    China
    India
    Japan


  South America

    Argentina
    Brazil


  Rest of World (ROW)

By Product Type Insights

The reagents and kits segment is estimated to witness significant growth during the forecast period.

The global IVD market is experiencing significant growth, with reagents and diagnostic kits being key components driving this expansion. Reagents, as chemical substances, play a crucial role in the detection and measurement of target analytes in patient samples. They facilitate various diagnostic tests, ranging from clinical chemistry to molecular diagnostics. Clinical chemistry applications account for a substantial portion of the market, with reagents used to measure substances like glucose, cholesterol, and enzymes in blood samples. These measurements contribute to the assessment of medical conditions such as diabetes and cardiovascular diseases.

Molecular diagnostics, another burgeoning segment, utilizes reagents for techniques like polymerase chain reaction (PCR) and next-generation sequencing. These advanced methods enable the identification of genetic mutations and infectious agents, offering valuable insights for personalized medicine and disease management. Diagnostic kits, which include reagents along with calibrators, controls, and sometimes instruments, provide a complete solution for specific diagnostic tests. They cater to diverse applications, such as urinalysis systems, immunofluorescence assays, microbiology systems, and hematology analyzers. Test performance metrics, such as sensitivity and specificity, are critical in ensuring diagnostic accuracy. Technological advancements, like real-time PCR, digita

The global in vitro diagnostics market is projected to witness a compound annual growth rate (CAGR) of 3.26% from 2022-2028, crossing $127.56 billion by 2028.

Available data formats for the Global In Vitro Diagnostics Market Size, Share, Opportunities, And Trends By Technique (Immunoassay, Molecular Diagnostics, Haematology, Other), By Application (Infectious Diseases, Autoimmune Diseases, Drug Testing, Oncology, Others), By End-User (Diagnostic Laboratories, Hospitals And Clinics, Research Laboratories And Institutes), And By Geography - Forecasts From 2025 To 2030 report.

According to Cognitive Market Research, the global IVD Raw Material market size was USD 15241.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 14.20% from 2024 to 2031.

North America held the major market share for more than 40% of the global revenue with a market size of USD 6096.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 4572.36 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 3505.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 762.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 304.82 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.
The antibody category is the fastest growing segment of the IVD Raw Material industry

Market Dynamics of IVD Raw Material Market

Key Drivers for IVD Raw Material Market

Increasing Global Incidences of Chronic Diseases to Boost Market Growth

The rise in the prevalence of chronic illnesses like diabetes, cancer, cardiovascular problems, and respiratory ailments mostly drives IVD raw material market growth. Demand for in vitro diagnostics (IVD) is rising as the worldwide burden of various diseases increases and the necessity for early diagnosis and ongoing monitoring grows. Utilized in labs, hospitals, and point-of-care settings, raw materials like enzymes, antibodies, and antigens are essential for creating precise diagnostic tests. The market for IVD tests and, by extension, the raw materials that make these tests possible is anticipated to witness steady expansion in the coming years as a result of population aging and health challenges associated with lifestyle choices that are fueling an increase in chronic diseases.

The Growing Adoption of Molecular Diagnostics to Drive Market Growth

The market for IVD raw materials is mostly driven by the rise of molecular diagnostics because these sophisticated procedures need highly specialized raw materials such as enzymes, nucleotides, antibodies, and antigens. Accurate outcomes in molecular diagnostics, which identify genetic mutations, infectious illnesses, and tailored medicine, depend on precise and sensitive reagents. The demand for premium raw materials has increased dramatically due to the growing applications of next-generation sequencing (NGS), CRISPR-based diagnostics, and polymerase chain reaction (PCR) procedures. The increasing emphasis in healthcare on early disease identification and customized therapies is driving a greater need for molecular diagnostics, which presents significant potential for raw material suppliers for these cutting-edge testing.

Restraint Factor for the IVD Raw Material Market

Limited Supply and Variable Price of Raw Materials Will Limit Market Growth

The market for IVD raw materials has several significant challenges, including the strain of innovation and unstable supply chains. The pricing comparison of these raw materials has a big impact on how profitable an IVD kit is. Any big change, such as shortages or price rises, maybe a significant challenge. A spike in material costs may result in lower profit margins for producers, who may be forced to raise prices, which may affect product availability. Furthermore, a lack of sufficient laboratory equipment, a reduction in manufacturing schedules, and a delay in releasing new items into the market could result from the scarcity. The IVD market is severely constrained by its unstable reliance on raw materials, which calls for innovative solutions to guarantee affordability and a dependable supply chain.

Impact of Covid-19 on the IVD Raw Material Market

The COVID-19 pandemic caused an unparalleled spike in demand for diagnostic tests and had a significant effect on the IVD raw material market. The virus spread quickly, creating a huge demand for PCR testing, antigen assays, and serological tests around the world. This, in turn, raised the requirement for raw materials such as enzymes, antibodies, viral ant...

Global in vitro diagnostics (IVD) market was valued at US$ 79.89 Billion in 2024 and is set to reach around US$ 137.29 Billion by 2034 at a CAGR of about 6.2% from 2025 to 2034.

Explore insights from Market Research Intellect's In Vitro Diagnostics(IVD) Market Report, valued at USD 76. 3 billion in 2024, expected to reach USD 101. 1 billion by 2033 with a CAGR of 4. 2% during 2026–2033. Uncover opportunities across demand patterns, technological innovations, and market leaders.